TY - JOUR T1 - Efficacy and cost of micronutrient treatment of childhood psychosis JF - BMJ Case Reports DO - 10.1136/bcr-2012-007213 VL - 2012 SP - bcr2012007213 AU - Megan Rodway AU - Annette Vance AU - Amany Watters AU - Helen Lee AU - Elske Bos AU - Bonnie J Kaplan Y1 - 2012/11/09 UR - http://casereports.bmj.com/content/2012/bcr-2012-007213.abstract N2 - Psychosis is difficult to treat effectively with conventional pharmaceuticals, many of which have adverse long-term health consequences. In contrast, there are promising reports from several research groups of micronutrient treatment (vitamins, minerals, amino acids and essential fatty acids) of mood, anxiety and psychosis symptoms using a complex formula that appears to be safe and tolerable. We review previous studies using this formula to treat mental symptoms, and present an 11-year-old boy with a 3-year history of mental illness whose parents chose to transition him from medication to micronutrients. Symptom severity was monitored in three clusters: anxiety, obsessive compulsive disorder and psychosis. Complete remission of psychosis occurred, and severity of anxiety and obsessional symptoms decreased significantly (p<0.001); the improvements are sustained at 4-year follow-up. A cost comparison revealed that micronutrient treatment was <1% of his inpatient mental healthcare. Additional research on broad-spectrum micronutrient treatment is warranted. ER -